发明名称 |
Gene expression markers for response to EGFR inhibitor drugs |
摘要 |
<p>The present invention concerns prognostic markers associated with cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed samples of cancer tissue, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.</p> |
申请公布号 |
EP2226396(A1) |
申请公布日期 |
2010.09.08 |
申请号 |
EP20100158352 |
申请日期 |
2004.05.28 |
申请人 |
GENOMIC HEALTH, INC.;CEDARS-SINAI MEDICAL CENTER |
发明人 |
BAKER, JOFFRE B.;SHAK, STEVE;AGUS, DAVID;NATALE, RONALD |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|